Avidity
Avidity is the overall strength of binding when many binding interactions happen together. It’s not just the sum of individual affinities, because when several interactions occur, they increase the chance that other interactions will form and stay bound, making the whole complex harder to break apart. This is especially important for large molecules that have multiple binding sites.
Affinity describes how strong a single binding event is. Avidity arises from having several interactions at once, and it depends on how molecules come together, including whether they form clusters or complexes and how they are oriented.
Antibodies illustrate avidity well. An antibody with many binding sites, like IgM, can bind strongly overall even if each site binds only weakly. By contrast, antibodies with fewer, stronger sites, such as IgG, IgE, and IgD, may have higher individual affinities but lower overall avidity in some situations.
In practice, scientists distinguish affinity from avidity when studying interactions. Affinity involves the balance of how fast sites bind and unbind, while avidity reflects the combined strength of all simultaneous bindings. Researchers use constants such as kon and koff to describe binding dynamics, and Ka (the inverse of Kd) to express overall binding strength.
Avidity tests help diagnose infections by showing whether someone’s immune system is currently actively reacting or has reacted in the past. Tests for viruses like rubella, CMV, HIV, and others can use different approaches, including traditional chaotropic methods and newer avidity-based assays. Advanced techniques such as switchSENSE and surface plasmon resonance are used to analyze how strongly molecules interact and how they come together.
This page was last edited on 2 February 2026, at 07:51 (CET).